163 related articles for article (PubMed ID: 35646380)
1. Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients.
de Las Heras B; Daehnke A; Saini KS; Harris M; Morrison K; Aguilo A; Chico I; Vidal L; Marcus R
Digit Health; 2022; 8():20552076221099997. PubMed ID: 35646380
[TBL] [Abstract][Full Text] [Related]
2. Remote Monitoring and Data Collection for Decentralized Clinical Trials.
Daly B; Brawley OW; Gospodarowicz MK; Olopade OI; Fashoyin-Aje L; Smart VW; Chang IF; Tendler CL; Kim G; Fuchs CS; Beg MS; Zhang L; Legos JJ; Duran CO; Kalidas C; Qian J; Finnegan J; Pilarski P; Keane H; Shen J; Silverstein A; Wu YL; Pazdur R; Li BT
JAMA Netw Open; 2024 Apr; 7(4):e246228. PubMed ID: 38607626
[TBL] [Abstract][Full Text] [Related]
3. From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials.
Dulko D; Kwong M; Palm ME; Trinquart L; Selker HP
J Clin Transl Sci; 2023; 7(1):e236. PubMed ID: 38028335
[TBL] [Abstract][Full Text] [Related]
4. The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.
Sessa C; Cortes J; Conte P; Cardoso F; Choueiri T; Dummer R; Lorusso P; Ottmann O; Ryll B; Mok T; Tempero M; Comis S; Oliva C; Peters S; Tabernero J
ESMO Open; 2022 Feb; 7(1):100339. PubMed ID: 34953404
[TBL] [Abstract][Full Text] [Related]
5. Ethical Considerations in Decentralized Clinical Trials.
Bierer BE; White SA
J Bioeth Inq; 2023 Dec; 20(4):711-718. PubMed ID: 38427177
[TBL] [Abstract][Full Text] [Related]
6. Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned.
Hanley DF; Bernard GR; Wilkins CH; Selker HP; Dwyer JP; Dean JM; Benjamin DK; Dunsmore SE; Waddy SP; Wiley KL; Palm ME; Mould WA; Ford DF; Burr JS; Huvane J; Lane K; Poole L; Edwards TL; Kennedy N; Boone LR; Bell J; Serdoz E; Byrne LM; Harris PA
J Clin Transl Sci; 2023; 7(1):e170. PubMed ID: 37654775
[TBL] [Abstract][Full Text] [Related]
7. The Patient Motivation Pyramid and Patient-Centricity in Early Clinical Development.
Iersel TV; Courville J; Doorne CV; Koster RA; Fawcett C
Curr Rev Clin Exp Pharmacol; 2022; 17(1):8-17. PubMed ID: 34455946
[TBL] [Abstract][Full Text] [Related]
8. Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors.
Kim YS; Kim A; Lee YS
Front Med (Lausanne); 2024; 11():1342184. PubMed ID: 38510454
[TBL] [Abstract][Full Text] [Related]
9. Quantifying Site Burden to Optimize Protocol Performance.
Florez M; Smith Z; Olah Z; Martin M; Getz K
Ther Innov Regul Sci; 2024 Mar; 58(2):347-356. PubMed ID: 38191957
[TBL] [Abstract][Full Text] [Related]
10. Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic.
Yeboa DN; Akinfenwa CA; Nguyen J; Amaya D; de Gracia B; Ning M; Cox V; De B; Smith BD; Lin L; Beddar S; Hoang H; Koong A; Liao Z
Adv Radiat Oncol; 2021; 6(3):100676. PubMed ID: 33686374
[TBL] [Abstract][Full Text] [Related]
11. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
[TBL] [Abstract][Full Text] [Related]
12. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.
Betcheva L; Kim JY; Erhun F; Oraiopoulos N; Getz K
Ther Innov Regul Sci; 2023 Sep; 57(5):1081-1098. PubMed ID: 37389795
[TBL] [Abstract][Full Text] [Related]
13. Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials.
Curtis A; Qu Y
Ther Innov Regul Sci; 2022 Sep; 56(5):744-752. PubMed ID: 35608729
[TBL] [Abstract][Full Text] [Related]
14. What role can decentralized trial designs play to improve rare disease studies?
Moore J; Goodson N; Wicks P; Reites J
Orphanet J Rare Dis; 2022 Jun; 17(1):240. PubMed ID: 35725484
[TBL] [Abstract][Full Text] [Related]
15. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
Tan AC; Ashley DM; Khasraw M
Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
[TBL] [Abstract][Full Text] [Related]
16. Deployment of an End-to-End Remote, Digitalized Clinical Study Protocol in COVID-19: Process Evaluation.
Zahradka N; Pugmire J; Lever Taylor J; Wolfberg A; Wilkes M
JMIR Form Res; 2022 Jul; 6(7):e37832. PubMed ID: 35852933
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report.
Gill S; Hao D; Hirte H; Campbell A; Colwell B
Curr Oncol; 2020 Apr; 27(2):71-74. PubMed ID: 32489248
[TBL] [Abstract][Full Text] [Related]
18. Using Technology to Enhance Cancer Clinical Trial Participation.
Haynes RM; Sirintrapun SJ; Gao J; McKenzie AJ
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-7. PubMed ID: 35486887
[TBL] [Abstract][Full Text] [Related]
19. Remaining Agile in the COVID-19 pandemic healthcare landscape - How we adopted a hybrid telemedicine Geriatric Oncology care model in an academic tertiary cancer center.
Chen M; Mohd Said N; Mohd Rais NC; Ho F; Ling N; Chun M; Ng YS; Eng WN; Yao Y; Korc-Grodzicki B; Pang A
J Geriatr Oncol; 2022 Jul; 13(6):856-861. PubMed ID: 35461791
[TBL] [Abstract][Full Text] [Related]
20. The use of telecommunication and virtualization among ongoing and discontinued COVID-19 clinical trials: A cross-sectional analysis.
Greenough MC; Sajjadi NB; Rucker B; Vassar M; Hartwell M
Contemp Clin Trials; 2022 Mar; 114():106681. PubMed ID: 35045363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
